Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04977141 · ClinicalTrials.gov registry record

Race, Ethnicity, Socioeconomic Status and Prolapse-rElated Decisional ConflicT

A clinical trial of Pelvic Organ Prolapse and Prolapse, Urogenital, sponsored by Women and Infants Hospital of Rhode Island.

Completed
Registry status
210
Enrollment target
1
Study location

NCT04977141: Completed study of Pelvic Organ Prolapse and Prolapse, Urogenital, sponsored by Women and Infants Hospital of Rhode Island.

NCT04977141 is a study of Pelvic Organ Prolapse and Prolapse, Urogenital that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 210 participants, above the 140-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (50% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04977141, a study of Pelvic Organ Prolapse and Prolapse, Urogenital, has completed, sponsored by Women and Infants Hospital of Rhode Island.

COMPLETED
Registry status
210 participants
Enrollment target
1
Study location

Study Summary

This study is trying to see if people from different backgrounds have different feelings when making treatment decisions about prolapse.

Interventions

  • OTHER Decisional Conflict Scale

Study Locations (1)

Rhode Island

  • Women & Infants Hospital - Providence

Trial Details

FieldValue
Enrollment Target 210 participants
Start Date 2021-07-07
Est. Completion 2024-05-01

What the finished NCT04977141 record still lists

NCT04977141 is an observational study that tracks outcomes without assigning an intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, above the 140-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (50% higher).

The record links to 2 conditions, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 1 intervention - of which Decisional Conflict Scale is the first listed.

NCT04977141 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT04977141 about?

NCT04977141 is a clinical study titled "Race, Ethnicity, Socioeconomic Status and Prolapse-rElated Decisional ConflicT". This study is trying to see if people from different backgrounds have different feelings when making treatment decisions about prolapse.

What is the current status of trial NCT04977141?

This trial is currently completed. The enrollment target is 210 participants. The study started on 2021-07-07. Estimated completion is 2024-05-01.

What conditions does trial NCT04977141 study?

This clinical trial studies the following conditions: Pelvic Organ Prolapse, Prolapse, Urogenital.

What interventions are being tested in trial NCT04977141?

The interventions under investigation include: Decisional Conflict Scale (OTHER).

Who is sponsoring clinical trial NCT04977141?

This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04977141 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Organ Prolapse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04977141's enrollment target sits among peer trials

210 6th of 40 higher than 35 of 40 other Pelvic Organ Prolapse trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pelvic Organ Prolapse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02665923 · 210 participants

    Gastric Emptying in Neonates and Infants After Formula Feeding

  • NCT03322891 · 210 participants · NA

    Improving Health Literacy in African-American Prostate Cancer Patients

  • NCT03544489 · 210 participants · Phase 2

    Effectiveness of Exercise After an ICD

  • NCT04408430 · 210 participants · NA

    The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04977141, the US trial registry maintained by the National Library of Medicine. NCT04977141 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.